Cefizox 500 IV Injection (as sodium) 500 mg Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

cefizox 500 iv injection (as sodium) 500 mg

شركة أدوية الحكمة - hikma pharmaceuticals - ceftizoxime (as sodium) 500 mg - (as sodium) 500 mg

CEFIZOX POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

cefizox powder for solution

glaxosmithkline inc - ceftizoxime sodium - powder for solution - 1g - ceftizoxime sodium 1g - third generation cephalosporins

CEFIZOX POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

cefizox powder for solution

glaxosmithkline inc - ceftizoxime sodium - powder for solution - 2g - ceftizoxime sodium 2g - third generation cephalosporins

Cefizox Injection IM 500 mg Μπαχρέιν - Αγγλικά - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

cefizox injection im 500 mg

maskati pharmacy - ceftizoxime sodium - injection im - 500

Cefizox Injection IV 1000 mg Μπαχρέιν - Αγγλικά - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

cefizox injection iv 1000 mg

maskati pharmacy - ceftizoxime sodium - injection iv - 1000

Anabact® IM 1 GM/1 VIL, 5 ml Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

anabact® im 1 gm/1 vil, 5 ml

الشركة الدولية للدواء - pharma international company - ceftizoxime sodium 1 gm/1 vil, lidocaine hydrochloride 5 ml - 1 gm/1 vil, 5 ml

Anabact® IV 1 GM/1 VIL Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

anabact® iv 1 gm/1 vil

الشركة الدولية للدواء - pharma international company - ceftizoxime sodium 1 gm/1 vil - 1 gm/1 vil

EPOCELIN Suppositories 125 (エポセリン坐剤125) Ιαπωνία - Αγγλικά - すりの適正使用協議会 RAD-AR Council, Japan

epocelin suppositories 125 (エポセリン坐剤125)

nihon generic co.,ltd - ceftizoxime sodium - white to yellowish white suppository, length: 21 mm

EPOCELIN Suppositories 250 (エポセリン坐剤250) Ιαπωνία - Αγγλικά - すりの適正使用協議会 RAD-AR Council, Japan

epocelin suppositories 250 (エポセリン坐剤250)

nihon generic co.,ltd - ceftizoxime sodium - white to yellowish white suppository, length: 25 mm

DALACIN C clindamycin 600 mg/4 mL (as phosphate) injection ampoule Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

dalacin c clindamycin 600 mg/4 ml (as phosphate) injection ampoule

pfizer australia pty ltd - clindamycin phosphate, quantity: 0 qs (equivalent: clindamycin, qty 150 mg/ml) - injection, solution - excipient ingredients: water for injections; benzyl alcohol; sodium hydroxide; disodium edetate; hydrochloric acid - indications as at 20 june 2005 : dalacin c phosphate is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. dalacin c phosphate is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin - allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. anaerobes - serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and skin structure infections; septicaemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, non-gonococcal tubo-ovarian abscess, pelvic cellulitis and post-surgical vaginal cuff infection, all when given in conjunction with an antibiotic of appropriate gram